Vizyco AU

Tag: obesity

  • Tirzepatide in Obesity: No AF Link but Arrhythmia Risk Noted | Eye scans detect signs of atrial f…

    Tirzepatide in Obesity: No AF Link but Arrhythmia Risk Noted | Eye scans detect signs of atrial f…

    Explore the latest developments concerning Tirzepatide in Obesity:.

    Tirzepatide in Obesity: No AF Link but Arrhythmia Risk Noted

    In adults with overweight or obesity, tirzepatide was not associated with increased odds of atrial fibrillation (AF) or atrial arrhythmia. Higher odds of any arrhythmia were observed, although event rates remained low and the evidence was not conclusive.

    "Although no clear association with AF or atrial arrhythmia was observed, the effect estimates for any arrhythmias suggested higher odds with tirzepatide. Because arrhythmias were not prespecified endpoints in most trials and event counts were low, these findings should be considered exploratory," the researchers wrote.

    The study was led by Ensieh S. Mansouri, MD, of Tehran University of Medical Sciences in Tehran, Iran. It was published online on September 9 in the Journal of the American Heart Association.

    2-Slice Toaster with Precision Control 6 Shade Settings Extra Wide Slots Countdown Timer Self-Centering Guides Bagel Defrost

    2-Slice Toaster with Precision Control 6 Shade Settings Extra Wide Slots Countdown Timer Self-Centering Guides Bagel Defrost
    Limited time offer! »

    The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

    For more detailed information, explore updates concerning Tirzepatide in Obesity:.

    For more news…

  • Many US patients opt for obesity drug injections, defying some expectations | Opinion | The Upsid…

    Many US patients opt for obesity drug injections, defying some expectations | Opinion | The Upsid…

    Explore the latest developments concerning Many US patients.

    Opinion | The Upside-Down World of the GLP-1 Bridge

    I spent 10 minutes in complete silence in my patient's room today, my eyes scanning lines of text in the electronic medical record. I wasn't looking for a life-threatening lab value or an undiscovered malignancy. I was hunting for an old diagnostic code for obstructive sleep apnea. When I finally found the assessment section of a sleep study from 2019, I celebrated. She had mild obstructive sleep apnea (OSA).

    My patient has class 3 obesity, prediabetes, hypertension, and mild (thankfully) OSA. With the recent trial launch of the federal Medicare GLP-1 Bridge program, American medicine has officially stepped into a contentious, bureaucratic "upside down" where being relatively healthier makes it easier to get treated, and being sicker can mean you're left behind. A subtle change from mild to moderate OSA would completely ruin her chances at receiving an affordable GLP-1 through the bridge program.

    HEALTH FIRST: New Medicare program offers low-cost GLP-1 weight loss drugs

    WILMINGTON, N.C. (WECT) – A new Medicare program is making select GLP-1 weight loss drugs more affordable for eligible patients, with costs as low as $50 a month.

    Dr. Kara Bird with Novant Health was in the studio to discuss the Medicare GLP Bridge Program and who qualifies.

    According to Dr. Bird, the program is available to Medicare Part D recipients who meet specific medical criteria, including:

    “Call your doctor. Ask if you qualify,” Dr. Bird said. “If you know you have Medicare Part D, see if you have those other qualifying factors.”

    35 Pieces/Set Carbide Tipped Router Bits, 1/4 Inch Shanks, Woodworking Router, Premium Woodworking Router Bit Set, Carbide Tippe

    35 Pieces/Set Carbide Tipped Router Bits, 1/4 Inch Shanks, Woodworking Router, Premium Woodworking Router Bit Set, Carbide Tippe
    Click for more info. »

    The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

    For more detailed information, explore updates concerning Many US patients.

    For more news…